Syverson Strege & Co’s BioMarin Pharmaceuticals BMRN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q2
Sell
-16
Closed -$1.56K 135
2023
Q1
$1.56K Buy
+16
New +$1.56K ﹤0.01% 537